TP53 and glioblastoma: The other 10% of GBM is identified as an IDH-mutant GBM, typically arising from LGGs, with genetic mutations in isocitrate dehydrogenase 1 (IDH1), tumor protein P53 (TP53), and alpha-thalassemia/intellectual disability X-linked (ATRX) [19,30].